Author
Listed:
- Khadija Khouz
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Rania Salhi
(University Hospital Center Ibn Rochd, University Hassan II, Morocco)
- Karima Ouadii
(University Hospital Center Ibn Rochd, University Hassan II, Morocco)
- Ghita Hatim
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Meryem Belhouari
(University Hospital Center Ibn Rochd, University Hassan II, Morocco)
- Tarik Chekrine
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Mouna Bourhafour
(University Hospital Center Ibn Rochd, University Hassan II, Morocco)
- Zineb Bouchbika
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Nadia Benchakroun
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Mehdi Karkouri
(University Hospital Center Ibn Rochd, University Hassan II, Morocco)
- Hassan Jouhadi
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Nezha Tawfik
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
- Souha Sahraoui
(University Hospital Centre Ibn Rochd, University Hassan II, Morocco)
Abstract
Plasmacytoid carcinoma is a rare and aggressive histological subtype of urothelial carcinoma, accounting for between 1% and 3% of urothelial carcinomas. The diagnostic confirmation relies on morphological and immunohistochemical analysis. We report the case of a 65-year-old male patient diagnosed with plasmacytoid urothelial carcinoma of the prostatic urethra (T4, N0, M0), with histological confirmation based on a biopsy obtained by transurethral resection. Immunohistochemical studies revealed positive epithelial markers and negative lymphoid markers. The patient underwent two cycles of systemic cisplatin-based chemotherapy. Surgery will be considered after further assessment. The therapeutic approach remains debated due to the heterogeneity of this histological subtype and its rarity. Radical cystectomy is the standard treatment for invasive muscle tumors without metastasis. Although cisplatin-based chemotherapy has been reported to be effective, local and metastatic recurrences are frequent. However, larger studies are needed to draw definitive conclusions and achieve consensus.
Suggested Citation
Khadija Khouz & Rania Salhi & Karima Ouadii & Ghita Hatim & Meryem Belhouari & Tarik Chekrine & Mouna Bourhafour & Zineb Bouchbika & Nadia Benchakroun & Mehdi Karkouri & Hassan Jouhadi & Nezha Tawfik , 2025.
"Urothelial Plasmacytoid Carcinoma of Urethral Location with Prostatic Invasion: A Case Report,"
European Journal of Medical and Health Sciences, European Open Science, vol. 7(5), pages 51-53, September.
Handle:
RePEc:epw:ejmed0:v:7:y:2025:i:5:id:42319
DOI: 10.24018/ejmed.2025.7.5.2319
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:7:y:2025:i:5:id:42319. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.